02/09/2024  10:25:08 Var. +0.170 Volume Denaro10:25:10 Lettera10:25:08 Capitalizzazione di mercato Dividend Y. Rapporto P/E
27.380EUR +0.62% 80,676
Fatturato: 2.2 mill.
27.370Quantità in denaro: 833 27.390Quantità in lettera: 867 24.79 bill.EUR 3.11% -

Descrizione business

Royal Philips is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Roy Jakobs
Consiglio di amministrazione
Abhijit Bhattacharya, Willem Appelo, Steve C de Baca, Jeff DiLullo, Marnix van Ginneken, Charlotte Hanneman, Andy Ho, Deeptha Khanna, Bert van Meurs, Edwin Paalvast, Shez Partovi, Heidi Sichien, Julia Strandberg
Consiglio di sorveglianza
Feike Sijbesma, Chua Sock Koong, Liz Doherty, Marc Harrison, Peter Löscher, Indra Nooyi, Sanjay Poonen, David Pyott, Benoît Ribadeau-Dumas, Paul Stoffels, Herna Verhagen
 

Dati aziendali

Name: Koninklijke Philips N.V.
Indirizzo: Amstelplein 2, Philips Center, Breitner Tower,NL-1070 MX Amsterdam
Telefono: +31-40-27-91111
Fax: -
E-mail: -
Internet: www.philips.com
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 83.42%
Data dell'IPO: 01/03/1995

Rapporti con gli investitori

Name: Leandro Mazzoni
IR telefono: +31-20-59-77-222
IR Fax: -
IR e-mail: investor.relations@philips.com

Company calendar

CW 44 | 28/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
84.05%
BlackRock, Inc.
 
5.19%
Treasury stock
 
4.08%
UBS Group AG
 
3.64%
T. Rowe Price Group Inc.
 
3.04%